Cannabinoids remove plaque-forming Alzheimer's proteins from brain cells (2016)

Age and status of the research

• The underlying Salk work is from 2016 and in vitro (cell culture), which several commenters flag as very preliminary.
• Some ask whether it led to anything; one link to a 2025 human trial is mentioned as “promising,” but details aren’t discussed.
• Skeptics note the absence of strong follow-up over nearly a decade.

Amyloid-beta hypothesis and plaque removal

• Multiple comments question whether clearing amyloid-beta plaques meaningfully treats Alzheimer’s, suggesting plaques may be a marker, not the root cause.
• Others point out existing monoclonal antibody drugs that remove amyloid and show modest slowing of progression, arguing this supports plaques being part of the disease process, even if not the whole story.
• One analogy says removing plaques could be like removing gravestones from a graveyard.

THC dosage, toxicity, and in vitro limits

• A technical commenter notes the observed effects occur at relatively high THC concentrations (≥0.1–1 µM), similar to levels that disrupt or kill neuronal cells in other studies.
• Back-of-the-envelope calculations suggest reaching these concentrations in humans would require extreme intake, likely not “recreational” and potentially harmful.
• Several emphasize that in vitro results are easy to publish but often not clinically useful.

User experiences with cannabis and anxiety

• Many report panic attacks or intense anxiety from modern high-THC products, even at low doses or with high-CBD strains.
• Others say anxiety is reduced with balanced THC:CBD products, cleaner lifestyle, aerobic exercise, or antidepressants, though all of this is anecdotal and highly individual.
• Some conclude the best solution for them is simply abstaining.

Cognitive effects and tradeoffs

• Commenters joke about “getting stupid now to avoid dementia later” and doubt chronic use improves memory.
• A few describe mixed effects: short-term memory impairment and scattered thinking, but also increased creativity, stress relief, and subjective focus for some.
• Long-term heavy use is viewed by several as likely harmful, though some report functioning well despite past heavy use.

Pain treatment and opioids (tangent)

• A long subthread compares cannabinoids to other painkillers.
• Participants debate risks of opioids (addiction, dependency) versus NSAIDs (bleeding, organ damage), arguing current pain management often forces patients to suffer.
• Some see non-opioid, non-NSAID analgesics (including cannabinoids) as a highly desirable but still incomplete alternative.

Risk of hype and misinterpretation

• Several warn that “compound X reduces amyloid in vitro” is a common, low bar finding and often becomes media hype.
• Concern is raised that the public may overinterpret such studies as “smoking weed prevents Alzheimer’s,” despite lack of clinical evidence.

Other suggested approaches

• Mentions of 40 Hz ultrasound and low-dose lithium appear as alternative or adjunctive avenues for Alzheimer’s prevention or treatment, but only briefly and with caveats.